• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moleculin Biotech, Inc. - Common Stock (NQ: MBRX )

    1.670 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 11
    Open 1.670
    Bid (Size) 1.400 (1)
    Ask (Size) 2.390 (20)
    Prev. Close 1.670
    Today's Range 1.670 - 1.670
    52wk Range 1.670 - 15.75
    Shares Outstanding 2,227,516
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    What's Going On With Moleculin Biotech Shares Wednesday?
    Moleculin Biotech shares are trading higher on Wednesday after the company announced the online publication of preclinical data for its Annamycin Venetoclax Resistant AML model. 
    Via Benzinga

    Performance

    YTD
    -87.95%
    -87.95%
    1 Month
    -38.83%
    -38.83%
    3 Month
    -38.38%
    -38.38%
    6 Month
    -53.74%
    -53.74%
    1 Year
    -82.82%
    -82.82%

    More News

    Read More
    Insights Ahead: Moleculin Biotech's Quarterly Earnings
    Via Benzinga
    MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
    Via InvestorPlace
    Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
    Via ACCESSWIRE
    MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
    Via InvestorPlace
    A Preview Of Moleculin Biotech's Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Earnings Scheduled For March 22, 2024
    Via Benzinga
    Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.